This course provides a framework describing the different types of lung disease and their potential effects on the patient.
You will learn how the clinician can recognise the patient presenting with the common or less common respiratory diseases and how he uses investigations to confirm the diagnosis of suspected respiratory diseases, and the key issues for their management.
Among other things you will learn about:
The TB lectures can be improved, In particular the approach to dx of a pt with suspected TB and in particular when you would consider tissue biopsy. Also the approach to dx of latent tb isn't clear. E,g performing a chest x-ray in high risk patient populations followed by mantoux testing. No mention of what size reaction is considered positive in different population ie immunosuppressed healthcare workers and the general population. The lecture discusses the treatment of active tb but no discussion of treating latent TB. No mention of when you would treat contacts of the index case. Finally serious side effects of TB treatment were not adequately covered. Isoniazid (need for B6 to decrease risk of peripheral neuropathy and megaloblastic anaemia) rifampicin and liver toxicity and drug interactions, ethambutol and occular toxicities and need for monitoring of visual fields and pyrazinamide (hepatoxicity).
This lecture series was very comprehensive and good level of detail. Obviously the Abx recommendations will vary according to where you work. To further improve the lectures in the future please include a small section on tropical respiratory infections.
I expected the pulmonary aspergillosis in brief too. However , there is concise pulmonary infection lecture.
Both questions and speech are excellent. The constant change between small details and the broad topic simplifies (and gives at least for me awareness of the affected organs in PE).